Adverse haematological effects of ticlopidine.
D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D005602:France; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D011358:Product Surveillance, Postmarketing; D013988:Ticlopidine / Q000009:adverse effects*; D014481:United States
D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine